Low pH induces co-ordinate regulation of gene expression in oesophageal cells

Carcinogenesis

Volumn 27, Issue 2, 2006, Pages 319-327

  Duggan, Shane P ^a   Gallagher, William M ^b   Fox, Edward J P ^b   Abdel Latif, Mohammed M ^a   Reynolds, John V ^a   Kelleher, Dermot ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; EARLY GROWTH RESPONSE FACTOR 4; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 34; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEIC ACID BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN AP 1F; PROTEIN AP4R; PROTEIN IRKS; PROTEIN P57; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

ANALYZER; ARTICLE; BINDING SITE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; COMPUTER PROGRAM; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; UNINDEXED SEQUENCE; VALIDATION PROCESS; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 31544479256     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi211     Document Type: Article

References (52)

1. McManus,D.T., Olaru,A. and Meltzer,S.J. (2004) Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res., 64, 1561-1569.
2. Jankowski,J.A., Wright,N.A., Meltzer,S.J., Triadafilopoulos,G., Geboes,K., Casson,A.G., Kerr,D. and Young,L.S. (1999) Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Pathol., 154, 965-973.
3. Wijnhoven,B.P., Tilanus,H.W. and Dinjens,W.N. (2001) Molecular biology of Barrett's adenocarcinoma. Ann. Surg., 233, 322-337.
4. Lagergren,J., Bergstrom,R., Lindgren,A. and Nyren,O. (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med., 340, 825-831.
5. Katz,P.O. (2004) Management of the patient with Barrett's esophagus: A continuing dilemma for the clinician. Rev. Gastroenterol Disord., 4, 49-59.
6. Eda,A., Osawa,H., Satoh,K., Yanaka,I., Kihira,K., Ishino,Y., Mutoh,H. and Sugano,K. (2003) Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J. Gastroenterol., 38, 14-22.
7. Tselepis,C., Perry,I., Dawson,C., Hardy,R., Darnton,S.J., McConkey,C., Stuart,R.C., Wright,N., Harrison,R. and Jankowski,J.A. (2002) Tumour necrosis factor-alpha in Barrett's oesophagus: A potential novel mechanism of action. Oncogene, 21, 6071-6081.
8. Riddell,R.H. (2005) The genesis of Barrett esophagus: Has a histologic transition from gastroesophageal reflux disease-damaged epithelium to columnar metaplasia ever been seen in humans? Arch. Pathol. Lab. Med., 129, 164-169.
9. Jankowski,J.A., Harrison,R.F., Perry,I., Balkwill,F. and Tselepis,C. (2000) Barrett's metaplasia. Lancet, 356, 2079-2085.
10. Fitzgerald,R.C. and Abdalla,S. (2003) Gastrin-induced hyperproliferation in Barrett's esophagus. Gastroenterology, 125, 1921; author reply 1921-1922.
11. Fitzgerald,R.C., Omary,M.B. and Triadafilopoulos,G. (1997) Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J. Cell Sci., 110 (Pt 5), 663-671.
12. Fitzgerald,R.C., Omary,M.B. and Triadafilopoulos,G. (1998) Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus. Am. J. Physiol., 275, G47-G55.
13. Van Der Woude,C.J., Kleibeuker,J.H., Jansen,P.L. and Moshage,H. (2004) Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastrointestinal tract. Apoptosis, 9, 123-130.
14. Abdel-Latif,M.M., O'Riordan,J., Windle,H.J., Carton,E., Ravi,N., Kelleher,D. and Reynolds,J.V. (2004) NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann. Surg., 239, 491-500.
15. O'Toole,D., Abdel-Latif,M.M., Long,A., Windle,H.J., Murphy,A.M., Bowie,A., O'Neill,L.A.J., Weir,D.G. and Kelleher,D. (2005) Low pH and Helicobacter pylori increase nuclear factor kappa b binding in gastric epithelial cells: A common pathway for epithelial cell injury? J. Cell Biochem., [Epub ahead of print].
16. Torigoe,T., Izumi,H., Yoshida,Y., Ishiguchi,H., Okamoto,T., Itoh,H. and Kohno,K. (2003) Low pH enhances Sp1 DNA binding activity and interaction with TBP. Nucleic Acids Res., 31, 4523-4530.
17. Skerka,C., Decker,E.L. and Zipfel,P.F. (1995) A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem., 270, 22500-22506.
18. Berendji,D., Kolb-Bachofen,V., Zipfel,P.F., Skerka,C., Carlberg,C. and Kroncke,K.D. (1999) Zinc finger transcription factors as molecular targets for nitric oxide-mediated immunosuppression: Inhibition of IL-2 gene expression in murine lymphocytes. Mol Med., 5, 721-730.
19. Abdel-Latif,M.M., Windle,H.J., Fitzgerald,K.A., Ang,Y.S., Eidhin,D.N., Li-Weber,M., Sabra,K. and Kelleher,D. (2004) Helicobacter pylori activates the early growth response 1 protein in gastric epithelial cells. Infect Immun., 72, 3549-3560.
20. McMahon,S.B. and Monroe,J.G. (1996) The role of early growth response gene 1 (egr-1) in regulation of the immune response. J. Leukoc. Biol., 60, 159-166.
21. Sukhatme,V.P., Cao,X.M., Chang,L.C. et al. (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell, 53, 37-43.
22. Sukhatme,V.P. (1990) Early transcriptional events in cell growth: The Egr family. J. Am. Soc. Nephrol., 1, 859-866.
23. Altorki,N., Schwartz,G.K., Blundell,M., Davis,B.M., Kelsen,D.P. and Albino,A.P. (1993) Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential. Cancer, 72, 649-657.
24. Heid,C.A., Stevens,J., Livak,K.J. and Williams,P.M. (1996) Real time quantitative PCR. Genome Res., 6, 986-994.
25. Gibson,U.E., Heid,C.A. and Williams,P.M. (1996) A novel method for real time quantitative RT-PCR. Genome Res., 6, 995-1001.
26. Jin,H., Yang,R., Awad,T.A. et al. (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation, 103, 736-742.
27. Quandt,K., Frech,K., Karas,H., Wingender,E. and Werner,T. (1995) MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res., 23, 4878-4884.
28. Hiraoka,S., Mizuno,M., Nasu,J., Okazaki,H., Makidono,C., Okada,H., Terada,R., Yamamoto,K., Fujita,T. and Shiratori,Y. (2004) Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus. J. Lab. Clin. Med., 143, 201-206.
29. Kuramochi,H., Vallbohmer,D., Uchida,K. et al. (2004) Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. J. Gastrointest. Surg., 8, 1007-1016; discussion 1016-1017.
30. Kawabe,A., Shimada,Y., Soma,T., Maeda,M., Itami,A., Kaganoi,J., Kiyono,T. and Imamura,M. (2004) Production of prostaglandinE2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells. Life Sci., 75, 21-34.
31. Shirvani,V.N., Ouatu-Lascar,R., Kaur,B.S., Omary,M.B. and Triadafilopoulos,G. (2000) Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology, 118, 487-496.
32. Shimokawa,N., Kumaki,I., Qiu,C.H., Ohmiya,Y., Takayama,K. and Koibuchi,N. (2005) Extracellular acidification enhances DNA binding activity of MafG-FosB heterodimer. J. Cell Physiol., 205, 77-85.
33. Barrett,M.T., Yeung,K.Y., Ruzzo,W.L., Hsu,L., Blount,P.L., Sullivan,R., Zarbl,H., Delrow,J., Rabinovitch,P.S. and Reid,B.J. (2002) Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. Neoplasia, 4, 121-128.
34. Xu,L., Fukumura,D. and Jain,R.K. (2002) Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: Mechanism of low pH-induced VEGF. J. Biol. Chem., 277, 11368-11374.
35. Rhodes,D.R., Yu,J., Shanker,K., Deshpande,N., Varambally,R., Ghosh,D., Barrette,T., Pandey,A. and Chinnaiyan,A.M. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia, 6, 1-6.
36. Welsh,J.B., Sapinoso,L.M., Su,A.I., Kern,S.G., Wang-Rodriguez,J., Moskaluk,C.A., Frierson,H.F.Jr and Hampton,G.M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61, 5974-5978.
37. Konturek,P.C., Nikiforuk,A., Kania,J., Raithel,M., Hahn,E.G. and Muhldorfer,S. (2004) Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: A possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig. Dis. Sci., 49, 1075-1083.
38. Croft,J., Parry,E.M., Jenkins,G.J., Doak,S.H., Baxter,J.N., Griffiths,A.P., Brown,T.H. and Parry,J.M. (2002) Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization. Eur. J. Gastroenterol Hepatol., 14, 1179-1186.
39. Doak,S.H., Jenkins,G.J., Parry,E.M., D'Souza,F.R., Griffiths,A.P., Toffazal,N., Shah,V., Baxter,J.N. and Parry,J.M. (2003) Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut, 52, 623-628.
40. Jenkins,G.J., Harries,K., Doak,S.H., Wilmes,A., Griffiths,A.P., Baxter,J.N. and Parry,J.M. (2004) The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25, 317-323.
41. Adamson,E.D. and Mercola,D. (2002) Egrl transcription factor: Multiple roles in prostate tumor cell growth and survival. Tumour Biol., 23, 93-102.
42. Krones-Herzig,A., Adamson,E. and Mercola,D. (2003) Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence. Proc. Natl Acad. Sci. USA, 100, 3233-3238.
43. Haverty,P.M., Hansen,U. and Weng,Z. (2004) Computational inference of transcriptional regulatory networks from expression profiling and transcription factor binding site identification. Nucleic Acids Res., 32, 179-188.
44. Haverty,P.M., Frith,M.C. and Weng,Z. (2004) CARRIE web service: automated transcriptional regulatory network inference and interactive analysis. Nucleic Acids Res., 32, W213-W216.
45. Ryser,S., Massiha,A., Piuz,I. and Schlegel,W. (2004) Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter. Biochem. J., 378, 473-484.
46. Barry,O.P., Mullan,B., Sheehan,D., Kazanietz,M.G., Shanahan,F., Collins,J.K. and O'Sullivan,G.C. (2001) Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent. J. Biol. Chem., 276, 15537-15546.
47. Mizuno,R., Oya,M., Shiomi,T., Marumo,K., Okada,Y. and Murai,M. (2004) Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells. J. Urol., 172, 723-727.
48. Small,G.W., Shi,Y.Y., Edmund,N.A., Somasundaram,S., Moore,D.T. and Orlowski,R.Z. (2004) Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an anti-apoptotic role. Mol. Pharmacol., 66, 1478-1490.
49. Morgan,C., Alazawi,W., Sirieix,P., Freeman,T., Coleman,N. and Fitzgerald,R. (2004) In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am. J. Gastroenterol., 99, 218-224.
50. Fan,F., Jin,S., Amundson,S.A. et al. (2002) ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene, 21, 7488-7496.
51. Kang,Y., Chen,C.R. and Massague,J. (2003) A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell., 11, 915-926.
52. Jolly,A.J., Wild,C.P. and Hardie,L.J. (2004) Acid and bile salts induce DNA damage in human oesophageal cell lines, Mutagenesis, 19, 319-324.